Townsend & Associates’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-155,118
Closed -$13.9M 116
2025
Q1
$13.9M Buy
155,118
+21,468
+16% +$2.22M 1.45% 33
2024
Q4
$13.8M Buy
133,650
+4,227
+3% +$492K 1.41% 32
2024
Q3
$17M Buy
129,423
+1,975
+2% +$270K 1.74% 24
2024
Q2
$16.6M Buy
127,448
+506
+0.4% +$71K 1.85% 19
2024
Q1
$16M Buy
126,942
+559
+0.4% +$63.7K 1.87% 19
2023
Q4
$12.7M Buy
126,383
+72,724
+136% +$6.71M 1.59% 29
2023
Q3
$4.61M Buy
53,659
+26,860
+100% +$2.76M 0.97% 36
2023
Q2
$3.27M Buy
26,799
+14,462
+117% +$1.72M 0.84% 42
2023
Q1
$1.53M Buy
12,337
+10,003
+429% +$1.21M 0.61% 62
2022
Q4
$277K Buy
+2,334
New +$206K 0.14% 88

Other funds holding CROX

Townsend & Associates's CROX Position: Q2 2025 in Review

Townsend & Associates sold out of Crocs (CROX) in Q2 2025, closing a stake of 155,118 shares — an estimated $13.9M sold.

Townsend & Associates first reported a position in CROX in Q4 2022 and held it in 10 quarters. The position peaked at $17M in Q3 2024. 506 funds tracked by Wall St. Rank hold CROX as of Q2 2025.

  • Townsend & Associates reported no remaining Crocs position as of Q2 2025 after selling out during the quarter.
  • Townsend & Associates sold 155,118 Crocs shares in Q2 2025, an estimated $13.9M.
  • Townsend & Associates first reported a position in Crocs in Q4 2022 and held it in 10 quarters.
  • Townsend & Associates's Crocs position peaked at $17M in Q3 2024.
  • 506 funds tracked by Wall St. Rank held Crocs as of Q2 2025.

Based on Townsend & Associates's 13F filing for Q2 2025, filed 30 Jul 2025.